AnaptysBio, Inc. lost $0.44 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters AnaptysBio, Inc. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
AnaptysBio, Inc. lost $0.44 per diluted share in fiscal year 2025.
AnaptysBio, Inc. (ANAB) reported a loss of $4.92 per diluted share in fiscal year 2024 and a loss of $0.44 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 11 fiscal years this page covers, AnaptysBio, Inc. (ANAB) diluted earnings per share went from -$2.12 in fiscal year 2015 to -$0.44 in fiscal year 2025.
AnaptysBio, Inc. (ANAB) reported $0.11 in diluted earnings per share in Q1 2027. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what AnaptysBio, Inc. (ANAB) reported on that line in every period on record.